Abstract
The incorporation of [α-32P]-uridine triphosphate into DNA transcription products was examined in short post-mortem interval (PMI) human brain neocortical nuclei (n, 22; PMI, 0.5–24 h) using run-on gene transcription. Reverse Northern dot-blot hybridization of newly synthesized RNA against either total cDNA or Alu repetitive DNA indicated that human brain neocortical nuclei of up to 4-h PMI were efficient in incorporating radiolabel into new transcription products, after which there was a graded decline in de novo RNA biosynthetic capacity. To test the effects of 0–3000 nM concentrations of ambient aluminum on RNA polymerase I (RNAP I) and RNA polymerase II (RNAP II) transcription, dot blots containing 0.5, 1.0, 2.0, and 5.0 µg of DNA for (1) the human-specific Alu repetitive element (2) the neurofilament light (NFL) chain, and (3) glial fibrillary acidic protein (GFAP) were Northern hybridized against newly synthesized radiolabeled total RNA. These DNAs represent heterogeneous nuclear RNA (hnRNA), neuronal-, and glial-specific markers, respectively. We report here a dose-dependent repression in the biosynthetic capabilities of brain RNAP II in the range of 50–100 nM aluminum, deficits similar to those previously described using a rabbit neocortical nuclei transcription system and at concentrations that have been reported in Alzheimer’s disease (AD) euchromatin. Transcription from RNAP II and the neuron-specific NFL gene in the presence of aluminum was found to be particularly affected. These findings support the hypothesis that brain gene transcription in the presence of trace amounts of ambient aluminum impairs mammalian brain DNA to adequately read out genetic information.
Similar content being viewed by others
References
Ahmad R., Naoui M., Neault J. F., Diamantoglou S., and Tajmir-Riahi H. A. (1996) An FTIR spectroscopic study of calf-thymus DNA complexation with Al(III) and Ga(III) cations. J. Biomol. Struct. Dyn. 13, 795–802.
Alzheimer A., Stelzmann R. A., Schnitzlein H. N., and Murtagh F. R. (1995) An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde.” Clin. Anat. 8, 429–431.
Amano R., Oishi S., Enomoto S., and Ambe F. (1996) Biodistribution of trace elements in normal, aluminum overloaded and cadmium overloaded mice. Ann. Clin. Lab. Sci. 26, 531–541.
Bertholf R. L., Herman M. M., Savory J., Carpenter R. M., Sturgill B. C., Katsetos C. D., Vandenberg S. R., and Wills M. R. (1989) A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal and neuronal cytoskeletal changes associated with systemic exposure. Toxicol. Appl. Pharmacol. 98, 58–74.
Bolla K., Briefel G., Spector D., Schwartz B. S., Wieler L., Herron J., and Gimenez L. (1992) Neurocognitive effects of aluminum. Arch. Neurol. 49, 1021–1026.
Bouras C., Giannakopoulos P., Good P. F., Hsu A., Hof P. R., and Perl D. P. (1997) A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer’s disease. Eur. Neurol. 38, 53–58.
Chen J. T., Lane M. A., and Clark D. P. (1996) Inhibitors of the polymerase chain reaction in Papanicolaou stain. Removal with a simple destaining procedure. Acta Cytol. 40, 873–877.
Chomczynski P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15, 532–536.
Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J., and De Boni, U. (1980) Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy and experimental aluminum encephalopathy. Acta Neuropath. 50, 19–24.
Crapper McLachlan D. R., Lukiw W. J., Mizzen C. A., and Kruck T. P. A. (1988) Chromatin structure in Alzheimer’s disease: Effect on 5′ leader sequence for NF-L gene and the role of aluminum. Alzheimer’s Dis. Related Disord. 2, 3–10.
De Boni U. and McLachlan D. R. (1980) Senile dementia and Alzheimer’s disease: a current view. Life Sci. 27, 1–14.
Del Castillo P., Llorente A. R., Gomez A., Gosalvez J., Goyanes V. J., and Stockert J. C. (1990) New fluorescence reactions in DNA cytochemistry. 2. Microscopic and spectroscopic studies on fluorescent aluminum complexes. Anal. Quant. Cytol. Histol. 12, 11–20.
Ehmann W. D. and Markesbery W. R. (1994) A multi-technique approach to the study of aluminum in Alzheimer’s disease brain. Life Chem. Rep. 11, 11–28.
Estable-Puig R. F. de, Estable-Puig J. F. de, and Romero C. (1971). Nuclear changes in glial cells after aluminum hydroxide. Virchows Arch. B. Cell Pathol. 8, 267–273.
Fei H., and Drake T. A. (1993). A rapid nuclear run-off transcription assay. Biotechniques 15, 838.
Forbes W. F. and Gentleman J. F. (1998) Risk factors, causality, and policy initiatives: the case of aluminum and mental impairment. Exptl. Gerontol. 33, 141–154.
Ganrot P. O. (1986) Metabolism and possible health effects of aluminum. Environ. Health Perspect. 65, 363–441.
Gelles J. and Landick R. (1998) RNA polymerase as a molecular motor. Cell 93, 13–16.
Guy S. P., Jones D., Mann D. M., and Itzhaki R. F. (1991) Human neuroblastoma cells treated with aluminium express an epitope associated with Alzheimer’s disease neurofibrillary tangles. Neurosci. Lett. 121, 166–168.
Hanas, J. S. and Gunn C. G. (1996) Inhibition of transcription factor IIIA-DNA interaction by xenobiotic metal ions. Nucleic Acids Res. 24, 924–930.
Hantson P., Mahieu P., Gersdorff M., Sindic C., and Lauwerys R. (1995) Fatal encephalopathy after otoneurosurgery procedure with an aluminum-containing biomaterial. J. Toxicol. Clin. Toxicol. 33, 645–648.
Hoang-Xuan K., Perrotte P., Dubas F., Philippon J., and Poisson F. M. (1996) Myoclonic encephalopathy after exposure to aluminum. Lancet 347, 910–911.
Hoffman P. N., Cleveland D. W., Griffin J. W., Landes P. W., Cowan N. J., and Price D. L. (1987) Neurofilament gene expression; a major determinant of axonal caliber. Proc. Natl. Acad. Sci. USA 84, 3472–3476.
Itzhaki R. (1994) The aetiology of Alzheimer’s disease, in Chapter 3, Molecular and Cell Biology of Neuropsychiatric Diseases, vol. 3 (Owen F. and Itzhaki R., eds.), Chapman and Hall, London, pp. 55–91.
Jeantet A. Y., Ballan-Dufrancais C., Petter C., and Truchet M. (1992) Mechanisms of cellular detoxication, nuclear aluminum concentration and hepatocyte protection after experimental overload in rats. C. R. Acad. Sci. III 315, 379–386.
Julka D., Vasishta R. K., and Gill K. D. (1996) Distribution of aluminum in different brain regions and body organs of rat. Biol. Trace Elem. Res. 52, 181–192.
Kadota T. and Kadota K. (1978) Neurofilament hypertrophy induced in the rabbit spinal cord after intracisternal injection of aluminum chloride. J. Toxicol. Sci. 3, 57–67.
Karlik S. J., Chong A. A., Eichhorn G. L., and De Boni U. (1989) Reversible toroidal compaction of DNA by aluminum. Neurotoxicology 10, 167–176.
Karlik S. J., Eichhorn G. L., Lewis P. N., and Crapper D. R. (1980) Interaction of aluminum species with deoxyribonucleic acid. Biochemistry 19, 5991–5998.
Kasas, S., Thomson N. H., Smith B. L., Hansma H. G., Zhu X., Guthold, M., Bustamante C., Kool E. T., Kashlev M., and Hansma P. K. (1997) Escherichia coli RNA polymerase activity observed using atomic force microscopy. Biochemistry 36, 461–468.
Kobayashi S., Hirota N., Saito K., and Utsuyama M. (1987) Aluminum accumulation in tangle-bearing neurons of Alzheimer’s disease with Balint’s syndrome in a long term aluminum refiner. Acta Neuropathol. 74, 47–52.
Kushelevsky A., Yagil R., Alfasi Z., and Berlyne G. M. (1976) Uptake of aluminum ion by the liver. Biomedicine 25, 59,60.
Lillie R. D., Donaldson P., Jirge S. K., and Pizzolato P. (1976) Iron and aluminum lakes of Gallo blue E as nuclear and metachromatic mucin stains. Stain Technol. 51, 187–192.
Llorente A. R., Del Castillo P., and Stockert J. C. (1989) Aluminium binding to chromatin DNA as revealed by formation of fluorescent complexes with 8-hydroxyquinoline and other ligands. J. Microsc. 155, 227–230.
Lovell M. A., Ehmann W. D., and Markesbery, W. R. (1993) Laser microprobe analysis of brain aluminum in Alzheimer’s disease. Ann. Neurol. 33, 36–42.
Lukiw W. J. (1997) Aluminum in alzheimer’s disease, in Mineral and Metal Neurotoxicology (Yasui M., Strong M., Ota K., and Verity M. A., eds.), CRC, Boca Raton, FL, pp. 113–126.
Lukiw W. J. and McLachlan D. R. C. (1995) Neurotoxicology of aluminum, in Handbook of Neurotoxicology II: Effects and Mechanisms, vol. 4 (Chang L. and Dyer R., eds.), Marcel Dekker, New York, 105–142.
Lukiw W. J., Bergeron C., Wong L., Kruck T. P. A., Krishnan B., and McLachlan D. R. C. (1992) Nuclear compartmentalization of aluminum in Alzheimer’s disease (AD). Neurobiol. Aging 13, 115–121.
Lukiw W. J., Kruck T. P. A., and McLachlan D. R. C. (1987) Alterations in human linker histone-DNA binding in the presence of aluminum salts in vitro and in Alzheimer’s disease. Neurotoxicology 8, 291–302.
Lukiw W. J., Kruck T. P. A., and McLachlan D. R. C. (1989a) Linker histone-DNA complexes; enhanced stability in the presence of aluminum lactate and implications for Alzheimer’s disease. FEBS Lett. 253, 59–62.
Lukiw W. J., Kruck T. P. A., and McLachlan D. R. C. (1989b) Aluminum, intracellular liganding and the nucleus. Lancet 1, 781.
Lukiw W. J., Rogaev E. I., and Bazan N. G. (1996) Synaptic and cytoskeletal RNA message levels in sporadic Alzheimer neocortex. Alzheimer’s Res. 2, 221–227.
Lukiw W. J., St. George-Hyslop P., and McLachlan D. R. C. (1994) Chromatin structure, nuclear aluminum and gene expression in Alzheimer’s disease, in Basic and Clinical Aspects of Neuroscience, vol. 6, Regulation of Gene Expression and Brain Function, Sandoz/Springer-Verlag, New York, pp. 31–45.
Marcheselli V. L. and Bazan N. G. (1996) Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J. Biol. Chem. 271, 24,794–24,799.
Martin R. B. (1992) Aluminium speciation in biology. Ciba Found. Symp. 169, 5–18.
Muma N. A. and Singer S. M. (1996) Aluminum-induced neuropathology: transient changes in microtubule-associated proteins. Neurotoxicol. Teratol. 18, 679–690.
Muma N. A., Troncoso J. C., Hoffman P. N., Koo E. H., and Price D. L. (1988) Aluminum neurotoxicity: altered expression of cytoskeletal genes. Brain Res. 427, 115–121.
Mundy W. R., Freudenrich T. M., and Kodavanti P. R. (1997) Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Mol. Chem. Neuropathol. 32, 41–57.
Nayak P. and Chatterjee A. K. (1998) Impact of protein malnutrition on subcellular nucleic acid and protein status of brain of aluminum-exposed rats. J. Toxicol. Sci. 23, 1–14.
Niedziela G. and Aniol A. (1983) Subcellular distribution of aluminum in wheat roots. Acta Biochim. Pol. 30, 99–105.
Oikarinen J., Mannermaa R. M., Tarkka T., Yli-Mayry N., and Majamaa K. (1991) Interference of AlF4-with nucleotide and DNA binding of rat histone H1 in vitro: implications for the pathogenesis of Alzheimer’s disease. Neurosci. Lett. 132, 171–174.
Parhad I. M., Krekoski C. A., Mathew A., and Tran P. M. (1989) Neuronal gene expression in aluminum myelopathy. Cell. Mol. Neurobiol. 9, 123–138.
Perl D. P. and Pendlebury W. W. (1984) Aluminum accumulation in neurofibrillary tangle-bearing neurons of senile dementia, Alzheimer’s type: detection by intraneuronal X-ray spectrometry studies of unstained tissue sections. J. Neuropathol. Exp. Neurol. 43, 349–359.
Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., and Gibbs C. J. (1982) Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217, 1053–1055.
Pesole G., Sbisa E., Mignotte F., and Saccone C. (1991) The branching order of mammals: phylogenetic trees inferred from nuclear and mitochondrial molecular data. J. Mol. Evolut. 33, 537–542.
Roeder R. G. and Rutter W. J. (1970) Specific nucleolar and nucleoplasmic RNA polymerases. Proc. Natl. Acad. Sci. USA 65, 675–682.
Sabouraud O., Chatel M., Menault F., Dien Peron J., Cartier F., Garre M., Gary J., and Pecker S. (1978) Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Rev. Neurol. (Paris) 134, 575–600.
Sanderson C., McLachlan D. R. C., and De Boni U. (1982) Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum. Acta Neuropathol. (Berl.) 57, 249–254.
Sarkander H. I., Balb G., Schlosser H., Stoltenburg G., and Lux R. M. (1983) Blockade of neuronal brain RNA initiation sites by aluminum: a primary molecular mechanism of aluminum-induced neurofibrillary changes? in Brain Aging: Neuropathology and Neuropharmacology, (Cervos-Navarro J. and Sarkander H. I., eds.), Raven, New York, pp. 259–274.
Schmid C. W. and Jelinek W. R. (1982) The Alu family of dispersed repetitive sequences. Science 216, 1065–1070.
Shimizu H., Mori T., Koyama M., Sekiya M., and Ooami H. (1994) A correlative study of the aluminum content and aging changes of the brain in non-demented elderly subjects. Nippon Ronen Igakkai Zasshi 31, 950–960.
Singer S. M., Chambers C. B., Newfry G. A., Norlund M. A., and Muma N. A. (1997) Tau in aluminum-induced neurofibrillary tangles. Neurotoxicology 18, 63–76.
Somova L. I., Missankov A., and Khan M. S. (1997) Chronic aluminum intoxication in rats: dose-dependent morphological changes. Methods Find. Exp. Clin. Pharmacol. 19, 599–604.
St. George-Hyslop P. (1995) Genetic determinants of Alzheimer disease. Prog. Clin. Biol. Res. 393, 139–145.
Stockert J. C. (1979) Observations on the chromatin staining by aluminum-hematoxylin. Z. Naturforsch. 34, 1285, 1286.
Tanzi R. E., Kovacs D. M., Kim T. W., Moir R. D., Guenette S. Y., and Wasco W. (1996) The gene defects responsible for familial Alzheimer’s disease. Neurobiol. Dis. 3, 159–168.
Thompson R. J. (1973) Studies on RNA synthesis in two populations of nuclei from the mammalian cerebral cortex. J. Neurochem. 21, 19–40.
Tokutake S., Nagase H., Morisaki S., and Oyanagi S. (1995) Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate. Neurosci. Lett. 185, 99–102.
Troncoso J., March J. L., Haner M., and Aebi U. (1990) Effect of aluminum and other multivalent cations on neurofilaments in vitro: an electron microscopic study. J. Struct. Biol. 103, 2–12.
Truchet M. (1976) Demonstration by electron probe microanalysis and by ionic microanalysis of nuclear localization of aluminum of various cells. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D. 282, 1785–1788.
Truchet M., Jeantet A. Y., and Petter C. (1987) Cell nucleus intervention in aluminum concentration by rat liver cells. C. R. Acad. Sci. III 305, 259–263.
Uemura E. (1984) Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes. Exp. Neurol. 85, 10–18.
Van Leeuwen F. W., de Kleijn D. P. V., van den Hurk H. H., Neubauer A., Sonnemans M. A. F., Sluijs J. A., Koycu S., Ramdjielal R. D. J., Salehi A., Martens G. J. M., Grosveld F. G., Burbach P. H., and Hol E. M. (1998) Frameshift mutants of B-amyloid precursor protein and ubiquitin-B in Alzheimers and Downs patients. Science 279, 242–247.
Walker P. R., LeBlanc J., and Sikorska M. (1989) Effects of aluminum and other cations on the structure of brain and liver chromatin. Biochemistry 28, 3911–3915.
Yasui M., Kihira T., and Ota K. (1992) Calcium, magnesium and aluminum concentrations in Parkinson’s disease. Neurotoxicology 13, 593–600.
Yasui M., Ota K., and Yoshida M. (1997) Effects of low calcium and magnesium dietary intake on the central nervous system tissues of rats and calcium-magnesium related disorders in the amyotrophic lateral sclerosis focus in the Kii Peninsula of Japan. Magnes. Res. 10, 39–50.
Yoshida S. (1991) Environmental factors in western Pacific foci of ALS and a possible pathogenetic role of aluminum (Al) in motor neuron degeneration. Rinsho Shinkeigaku 31, 1310–1312.
Yoshida S., Mitani K., Wakayama I., Kihira T., and Yase Y. (1995) Bunina body formation in amyotrophic lateral sclerosis: a morphometric-statistical and trace element study featuring aluminum. J. Neurol. Sci. 130, 88–94.
Yumoto S., Kakimi S., Matsushima H., Ishikawa A., and Mizutani T. (1998) Aluminum accumulation in the brains of patients with Alzheimer’s disease. Abstract 1139, 6th International Conference on Alzheimer’s Disease and Related Disorders, 18–23 July, Amsterdam, The Netherlands.
Zhang Y. (1995) Effects of aluminum chloride on the nucleus and nucleolus in root tip cells of Hordeum vulgare. Mutat. Res. 335, 137–142.
Zubenko G. S., Stiffler J. S., Hughes H. B., Hurtt M. R., and Kaplan B. B. (1998) Initial results of a genome survey for novel Alzheimer’s disease risk genes: association with a locus on the X chromosome. Am. J. Med. Genet. 81, 98–107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lukiw, W.J., LeBlanc, H.J., Carver, L.A. et al. Run-on gene transcription in human neocortical nuclei. J Mol Neurosci 11, 67–78 (1998). https://doi.org/10.1385/JMN:11:1:67
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:11:1:67